- WHY CARE ABOUT MYANMAR?
- WHO WE ARE
Local leaders, global support to defeat malaria in Myanmar.
Myanmar has the second highest number of malaria deaths in Southeast Asia, and the disease hits pregnant women and children particularly hard. In eastern Myanmar, malaria kills one-quarter of the children who die before their fifth birthday, and is the leading cause of maternal anemia, stillbirth, premature birth and low birth weight.
In addition to entrenched endemic malaria, eastern and northern Myanmar face the spread of drug resistance to front-line anti-malarial drugs — a potential global disaster in the fight against malaria since Myanmar was once before the epicenter of drug resistance that spread to Africa.
CPI’s CLEAR (Community Leaders Eliminating Artemisinin Resistance) Malaria Project–Myanmar is supported by a $1.5 million grant from the Three Millennium Development Goal (3MDG) Fund. Implemented by our local partner organizations, the project improves access to early diagnosis and treatment, treated bed nets and community education for 225,000 villagers in the areas identified as highest risk by the Global Plan for Artemisinin Resistance Containment.
In a groundbreaking arrangement, given Myanmar’s long history of civil strife and mistrust, a majority of the 3MDG funds go directly to our ethnic partner organizations: Burma Medical Association, Kachin Baptist Convention, Karen Baptist Convention, Karen Department of Health and Welfare, Karenni Mobile Health Committee, Mon National Health Committee.
Community Partners International has more than 15 years’ experience in the field, providing our local partners skills training, focused mentoring and resource support to build their ability to lead and manage health programs that will strengthen the emerging national health system.